ARCHIVES

J&J Withdraws Power Morcellators, Citing Risk of Disseminating Cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 31 | August 1, 2014

Download PDF Visit The Full Archive

Related Articles

Studies Are Demonstrating Effectiveness of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

April 5, 1974

Upton Leaning to New Division for Centers, Organ Sites, Education

August 25, 1978

Phase III Trial: Panobinostat Increases PFS by Four Months

September 26, 2014

Obey Erred On Criticism Of Pap Test Cost, FCRC Construction

August 10, 1979

Gallo’s Lab Moved From DCT to DCE; NCI Planning To Drop “Cancer Treatment Reports” At End Of ‘86

February 6, 1987

Excerpts Presented From Pepper Hearing

July 20, 1979